Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

Completed · Phase 1

Conditions studied: Metastatic Liver Cancer

In brief

This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.

Key facts

Study ID

NCT00604409

Run by

Fox Chase Cancer Center

People needed

34

Starts

2006-04-01

Expected to finish

2015-01-01

Last updated by the study team

2015-09-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adequate liver function
• Adequate performance status

You may not qualify if…

• Significant extrahepatic disease

Where it is running

• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.